Bruker Corp. Stock
Bruker Corp. Stock
Bruker Corp. took a tumble today and lost -€1.980 (-3.550%).
We see a rather positive sentiment for Bruker Corp. with 15 Buy predictions and 1 Sell predictions.
On the other hand, the target price of 52 € is below the current price of 54.48 € for Bruker Corp., so the potential is actually -4.55%.
Our community identified positive and negative aspects for Bruker Corp. stock for the coming years. 0 users see the criterium "Revenue growth" as a plus for the Bruker Corp. stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | -3.550% | 2.445% | 3.417% | 61.758% | 33.562% | -13.524% | - |
| Healthequity Inc. | -3.310% | 6.707% | 11.465% | 2.941% | 12.179% | 49.573% | 40.585% |
| Omnicell Inc. | -10.670% | -10.674% | -10.169% | 17.778% | -18.041% | -44.211% | -73.051% |
| Myriad Genetics | 3.610% | -7.568% | -6.972% | 30.424% | -12.887% | -76.915% | -82.740% |
Comments
Bruker (BRKR) had its price target raised by Leerink Partners from $60.00 to $70.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its "buy" rating reaffirmed by Guggenheim.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target raised by JPMorgan Chase & Co. from $55.00 to $65.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
News
Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam
Key Points
- Interested in Bruker Corporation? Here are five stocks we like better.
- Order momentum is improving across Bruker’s business, with semiconductor metrology, overseas
